These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 31350594)

  • 1. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
    Singh S; Gautam AS
    Curr Atheroscler Rep; 2019 Jul; 21(10):38. PubMed ID: 31350594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Cell Physiol Biochem; 2016; 38(5):1851-9. PubMed ID: 27160316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
    Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOX-1, OxLDL, and atherosclerosis.
    Pirillo A; Norata GD; Catapano AL
    Mediators Inflamm; 2013; 2013():152786. PubMed ID: 23935243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
    Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
    J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.
    Xu S; Ogura S; Chen J; Little PJ; Moss J; Liu P
    Cell Mol Life Sci; 2013 Aug; 70(16):2859-72. PubMed ID: 23124189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.
    Lu J; Yang JH; Burns AR; Chen HH; Tang D; Walterscheid JP; Suzuki S; Yang CY; Sawamura T; Chen CH
    Circ Res; 2009 Mar; 104(5):619-27. PubMed ID: 19150883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.
    Ou HC; Chou WC; Hung CH; Chu PM; Hsieh PL; Chan SH; Tsai KL
    Environ Toxicol; 2019 Jul; 34(7):825-835. PubMed ID: 30963716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
    Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH
    Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin-Like Oxidized Low-Density Lipoprotein Receptor (Lox-1), Thyroid Hormone (T3) And Reactive Oxygen Species (Ros): Possible Cross-Talk In Angiogenesis.
    Balzan S; Sabatino L; Lubrano V
    Theor Biol Forum; 2017 Jan; 110(1-2):13-23. PubMed ID: 29687829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
    Reiss AB; Anwar K; Wirkowski P
    Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LOX-1 receptor: A potential link in atherosclerosis and cancer.
    Balzan S; Lubrano V
    Life Sci; 2018 Apr; 198():79-86. PubMed ID: 29462603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.
    Mattaliano MD; Huard C; Cao W; Hill AA; Zhong W; Martinez RV; Harnish DC; Paulsen JE; Shih HH
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1329-37. PubMed ID: 19279231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase-Oxidized LDL Activates Human Aortic Endothelial Cells through the LOX-1 Scavenger Receptor.
    El-Hajjar L; Hindieh J; Andraos R; El-Sabban M; Daher J
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOX-1 and ROS, inseparable factors in the process of endothelial damage.
    Lubrano V; Balzan S
    Free Radic Res; 2014 Aug; 48(8):841-8. PubMed ID: 24886290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.
    Pothineni NVK; Karathanasis SK; Ding Z; Arulandu A; Varughese KI; Mehta JL
    J Am Coll Cardiol; 2017 Jun; 69(22):2759-2768. PubMed ID: 28571642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.
    Arjuman A; Chandra NC
    Diab Vasc Dis Res; 2013 Sep; 10(5):442-51. PubMed ID: 23811604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.
    Akhmedov A; Rozenberg I; Paneni F; Camici GG; Shi Y; Doerries C; Sledzinska A; Mocharla P; Breitenstein A; Lohmann C; Stein S; von Lukowicz T; Kurrer MO; Borén J; Becher B; Tanner FC; Landmesser U; Matter CM; Lüscher TF
    Eur Heart J; 2014 Oct; 35(40):2839-48. PubMed ID: 24419805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of LOX-1 in microvascular dysfunction.
    Lubrano V; Balzan S
    Microvasc Res; 2016 May; 105():132-40. PubMed ID: 26907636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
    Mehta JL; Chen J; Hermonat PL; Romeo F; Novelli G
    Cardiovasc Res; 2006 Jan; 69(1):36-45. PubMed ID: 16324688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.